Concepedia

Pembrolizumab for metastatic triple-negative breast cancer (mTNBC): long-lasting responses in the phase Ib KEYNOTE-012 study

Rachita Nanda, Jennifer M. Specht, E. Claire Dees, Ranaan Berger, Sanjeev Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Amitabha Ray, Vassiliki Karantza,

European Journal of Cancer · 2017 · 10 citations · 0 references

Concepts

MedicineOncologyPharmacologyBreast OncologyImmunotherapyMetastasisBreast Cancer PharmacotherapyCancer ImmunotherapyImmunotherapy For Breast CancerMetastatic Breast CancerMetastatic Cancer ManagementMetastatic Disease TreatmentBreast Cancer Response AssessmentMetastatic Breast Cancer TreatmentPembrolizumab TherapyTriple-negative Breast Cancer ImmunotherapyTriple-negative Breast Cancer TherapyTriple-negative Metastatic Disease